Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors

Completed · Phase 1

Conditions studied: Sarcoma, Ewing's

In brief

This is a phase 1 study of anti-IGF-IR CP-751,871 in patients with solid tumors currently enrolling patients 9 years old and older with Ewing's sarcoma family of tumors (Ewing's, PNET and Askin's).

Key facts

Study ID

NCT00474760

Run by

Pfizer

People needed

65

Starts

2005-08-01

Expected to finish

2012-10-01

Last updated by the study team

2013-12-17

Who can join

Age: 9 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Ewing's sarcoma family tumors

You may not qualify if…

• Concurrent treatment with any other anti tumor agents

Where it is running

• Pfizer Investigational Site — Ann Arbor, Michigan, United States
• Pfizer Investigational Site — Rochester, Minnesota, United States
• Pfizer Investigational Site — Sutton, Surrey, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.